Extending the Benefits of Immunotherapy

An urgent question for cancer scientists is why immunotherapy achieves dramatic results in some cases but doesn’t help most patients. A recent article outlines independent discoveries, led by two research … Continue reading “Extending the Benefits of Immunotherapy”

DF/HCC Celebration of Junior Investigators

The Dana-Farber/Harvard Cancer Center’s annual Celebration of Junior Investigators is fast approaching, and the application submission deadline has been extended until tomorrow, October 11th. Please consider submitting an application if you meet … Continue reading “DF/HCC Celebration of Junior Investigators”

Alumni Interview with Marian Ewell

Marian Ewell, ScD ’93 Senior Vice President, The Emmes Corporation Where do you currently work and what are your job responsibilities? After my post-doc experience at the Dana-Farber Cancer Institute, … Continue reading “Alumni Interview with Marian Ewell”

Braun & Parmigiani Receive Footbridge Grant

As members of a team composed of investigators from Dana-Farber Cancer Institute, Massachusetts General Hospital, and the Massachusetts Institute of Technology, Research Fellow Danielle Braun and DFCI Biostatistics Chair & Professor Giovanni Parmigiani … Continue reading “Braun & Parmigiani Receive Footbridge Grant”

Marvin Zelen Memorial Symposium

The 2017 Dana-Farber Cancer Institute/Frontier Science Technology and Research Foundation Marvin Zelen Memorial Symposium is honored to present “Contemporary Statistical Challenges in Clinical Research”, a tribute to Richard Gelber on … Continue reading “Marvin Zelen Memorial Symposium”

Dave Harrington Symposium

On October 28th, faculty, students, alumni, and staff gathered in the Boston Red Sox Jimmy Fund Auditorium at the Dana-Farber Cancer Institute to celebrate David Harrington’s 70th birthday and to honor … Continue reading “Dave Harrington Symposium”